Supervisor: Dr Thomas Burnett
Partners: Novartis
This project is offered by the EPSRC Centre for Doctoral Training in Statistical Applied Mathematics (SAMBa), for study commencing in September 2026.
Adaptive designs for clinical trials add flexibility to the clinical development process, using pre-planned interim analyses to allow alterations to the trial in progress. Such flexibility gives trials the potential to be more efficient and ethical, and these goals may be prioritised differently in different forms of adaptation.
Adaptive designs introduce further complication to the proper estimation of treatment effects compared to traditional fixed sampling designs. Decisions about trial modifications are typically based on the observations available at the time of the interim analysis and, since the final set of data is itself data-dependent, standard methods for deriving estimates and confidence intervals are not applicable. The recent publication of the ICH E20 draft Guideline on Adaptive Clinical Trials highlights the need to use appropriate estimation methods to inform cost-benefit decision making.
In this project the student will explore the problem of inference after a trial with an adaptive design. Research will be conducted to investigate trade-offs of different estimation methods and the impact of different choices for conditional estimation based on the decision that may be made. The work will be conducted in close collaboration with project partners at Novartis. This close collaboration with industry will allow the student to grow their professional network within the pharmaceutical industry. Working with an industrial supervisor will ensure the research keeps the practical implications of the problem as a core priority, leading to real world impact.
Keywords: clinical trials, adaptive designs, statistical inference, simulation studies
Approximate timeline
In the first 9 months – As a SAMBA student, you will complete the SAMBa training programme.
Year 1/2 – Review relevant literature; construct a general framework for the research; identify limitations with the current approaches, both theoretically and empirically (via simulations).
Year 3 – Develop guidelines for the implementation of different point and interval estimation methods for specific forms of adaptation, determining key questions through collaboration between the student and industrial partner. Begin dissemination of the research to the relevant communities. Prepare a paper for publication in a high quality Statistics Journal.
Year 4 – Explore generalisations of the proposed methods to trial designs with different forms of adaptation; identify theoretical advantages of the proposed methods over existing methods; consider possible extensions to the research findings so far; disseminate research results through presentations and further publications; prepare the PhD thesis.
Training and Development Opportunities
In addition to all the benefits of the SAMBa training course, you will have the opportunity for summer internships at Novartis in Basel, Switzerland. You will be given networking opportunities within the academic community and the pharmaceutical industry. This will involve attending and presenting at workshops, conferences and seminars. There will be additional career development opportunities through attending events such as the UK Young Statisticians’ Meeting, the UK Research Students Conference, and the annual conference held by PSI (Statisticians in the Pharmaceutical Industry).
Candidate Requirements
In addition to the SAMBa entrance requirements, the ideal candidate will have a strong understanding of the fundamentals of statistics (through either undergraduate studies or postgraduate taught studies). Experience in programming in statistical software such as R and experience in clinical trials or medical statistics is desirable.
Contact the SAMBa team at samba@bath.ac.uk if you are unsure about your eligibility and would like to discuss your potential application.
Enquiries and Applications
Informal enquiries are encouraged and should be directed to supervisor Dr Thomas Burnett tb292@bath.ac.uk
Applications are open for entry in September 2026. Apply via the University of Bath’s online application form for an Integrated PhD in Statistical Applied Mathematics. Early applications are encouraged.
IMPORTANT:
When completing the application form:
There were a couple of ongoing personal research collaborations with Novartis in the Department of Mathematical Sciences that were brought together to develop a set of challenges for Novartis’s participation in ITT12. These consisted of questions exploring modelling and data integration in pharmacokinetics models, and finding effective routes to drug development for liver disease.
"Working with SAMBa students to relay how our industry understands the daily challenges in aerospace design and manufacture and for them to translate them into statistical/mathematical models and methods was a refreshing and rewarding concept."
"The collaboration between SAMBa, UNAM and CIMAT has strengthened us in tools and techniques to visualize new perspectives of development and collaboration with a focus on generating value for other institutions."
"We found participating in the ITT to be an unique and engaging environment for exchanging ideas and it was also good fun. Above all it produced some truly innovative thinking."
"The students at SAMBa were engaging and motivated, above all interested in solving real world problems with their skills. As a result of SAMBa we have taken huge strides forward in a new technique in the assessment of arthritis related to psoriasis and the effect of treatment.
“We have a great track record of successful collaboration with SAMBa, as we share a common aim – applying the latest thinking in mathematics and statistics to solve real-world problems."
“Alongside the specific potential benefits to applied flood and coastal risk management, I have seen first-hand that the SAMBa CDT produces high calibre doctoral graduates with excellent skills in problem formulation and collaborative problem solving...”
"We are working with SAMBa to develop new tools for managing risk by combining deterministic and probabilistic methods."
"For a small company like ours, this research is vital in delivering our vision to create digital technologies that change what’s possible for clinicians and patients."